Viewing Study NCT04713592


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2026-01-01 @ 9:44 PM
Study NCT ID: NCT04713592
Status: COMPLETED
Last Update Posted: 2024-06-14
First Post: 2021-01-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement
Sponsor: AbbVie
Organization: